Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LLY - AbCellera Biologics: Many Reasons To Own This Undervalued Stock

LLY - AbCellera Biologics: Many Reasons To Own This Undervalued Stock

Eli Lilly and Company

Summary

  • AbCellera Biologics is an undervalued, profitable, drug discovery stock with a $3B market cap.
  • AbCellera Biologics has a flawless balance sheet with no debt in the last five years and $1.1B in cash and cash equivalents.
  • This company has capital and operational efficiency leading to current gross margins of nearly 74% and net profit margins at 39.5%.
  • Partnerships continue to grow with pharmaceutical companies and venture capitalist firms for drug discoveries.

For further details see:

AbCellera Biologics: Many Reasons To Own This Undervalued Stock
Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...